Abich Financial Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Abich Financial Wealth Management's XBI Position: Q3 2025 in Review
Abich Financial Wealth Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2025: 25 shares worth $2.5K. The stake represents ﹤0.01% of the portfolio and ranks #558 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in XBI as recently as Q2 2024.
Abich Financial Wealth Management first reported a position in XBI in Q2 2024 and has held it in 2 quarters since. The position peaked at $3.52K in Q2 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- Abich Financial Wealth Management held 25 shares of State Street SPDR S&P Biotech ETF worth $2.5K as of Q3 2025.
- State Street SPDR S&P Biotech ETF was a new Abich Financial Wealth Management position in Q3 2025.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Abich Financial Wealth Management's portfolio in Q3 2025, its #558 holding.
- Abich Financial Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 2 quarters since.
- Abich Financial Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $3.52K in Q2 2024.
- 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.